• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

High Variability in Antibody Titer Determination in Transfusion Medicine

March 2, 2023

Antibody levels are important for many aspects of clinical care from evaluating the incompatibility of transfusions and transplants to determining certain diagnoses such as hemolytic reactions.  Although no gold standard exists to determine antibody levels, the majority of assays depend on titration and grading the strength of agglutination, which has been performed manually and is operator dependent.  The uniform procedure uses a weak positive titration endpoint to reduce variability, but substantial variation still exists between assays and laboratories.  In order to better understand the testing accuracy and variation between and within laboratories, the College of American Pathologists (CAP) analyzed antibody titer proficiency data (10,852 responses for anti-D and 5,680 responses for anti-A, collected twice per year) from 2014 to 2018 from 1337 U.S. and international laboratories.  Overall, only 54.1% (5874/10,852) of anti-D tests and 63.4% (3603/5680) of anti-A tests were accurate within one titer.  When two samples with the same titer were titrated in the same laboratory, 85% of laboratories using the uniform procedure and 80% using other methods reported a titer difference of one or less.   Given the strong reliance on antibody titer results for clinical diagnostics, further standardization of antibody titers is needed.

Reference:

Karafin MS, DeSimone RA, Dvorak J, Metcalf RA, Pagano MB, Park YA, Schwartz J, Souers RJ, Szczepiorkowski ZM, Uhl L, Ramsey G. Antibody Titers in Transfusion Medicine: A Critical Reevaluation of Testing Accuracy, Reliability, and Clinical Use. Arch Pathol Lab Med. 2023 Feb 2. doi: 10.5858/arpa.2022-0248-CP. Epub ahead of print. PMID: 36730468.

Filed Under

  • News
  • Quality Control and Regulatory

Recommended

  • Phase 1 Trial Results for Lentiviral Gene Therapy for Patients with Hemophilia A

  • Pathogen-Reduction May Help Prevent Alloimmune Platelet Refractoriness

  • Randomized Trial of Platelet Transfusions and Risk of Bleeding before CVC Placement

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Storage Duration Affects Hematological and Metabolic Parameters in Patients with Sickle Cell Disease

  • Syphilis Infections Among US Blood Donors

  • RBCs with Reduced Deformability are Removed from Circulation

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley